Advertisement
Screener

Rosetta Genomics Ltd. Stock-Based Compensation

Rosetta Genomics Ltd. Stock-Based Compensation

Rosetta Genomics Ltd. reported Stock-Based Compensation of $396.00 thousand for the 6-month period ending 2017-06-30, per its 6-K filed 2017-10-10.

Discontinued › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2017-10-10

Period endShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2017-06-30$396.00K
6-K · filed 2017-10-10
2016-12-31$859.00K
6-K · filed 2017-10-10
2016-06-30$459.00K
6-K · filed 2017-10-10
2015-12-31$1.02M
6-K · filed 2017-10-10
2015-06-30$544.00K
6-K · filed 2016-09-26
2014-12-31$943.00K
6-K · filed 2017-10-10
2014-06-30$471.00K
6-K · filed 2015-10-26
2013-12-31$893.00K
6-K · filed 2016-12-08
2013-06-30$467.00K
6-K · filed 2014-09-17
2012-12-31$549.00K
20-F · filed 2015-03-16
2012-06-30$158.00K
6-K · filed 2013-09-09
2011-12-31$604.00K
20-F · filed 2014-03-31
$603.00K
20-F/A · filed 2012-05-01
2011-06-30$512.00K
6-K · filed 2012-09-28
2010-12-31$737.00K
20-F · filed 2013-03-22
2009-12-31$1.37M
6-K · filed 2012-12-07